rs137853086
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004482.4(GALNT3):c.484C>T(p.Arg162Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004482.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALNT3 | NM_004482.4 | c.484C>T | p.Arg162Ter | stop_gained | 2/11 | ENST00000392701.8 | NP_004473.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALNT3 | ENST00000392701.8 | c.484C>T | p.Arg162Ter | stop_gained | 2/11 | 1 | NM_004482.4 | ENSP00000376465 | P1 | |
GALNT3 | ENST00000412248.5 | c.484C>T | p.Arg162Ter | stop_gained | 3/8 | 5 | ENSP00000412643 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251320Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135834
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727238
GnomAD4 genome AF: 0.000191 AC: 29AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74364
ClinVar
Submissions by phenotype
Tumoral calcinosis, hyperphosphatemic, familial, 1 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2005 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Apr 27, 2023 | PVS1, PM2, PM3 - |
Pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Oct 15, 2018 | This variant is interpreted as Pathogenic, for Tumoral calcinosis, hyperphosphatemic, familial, 1, autosomal recessive. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PVS1-Strong => PVS1 downgraded in strength to Strong. PP1-Moderate => PP1 upgraded in strength to Moderate (https://www.ncbi.nlm.nih.gov/pubmed/15133511). PM3 => For recessive disorders, detected in trans with a pathogenic variant (https://www.ncbi.nlm.nih.gov/pubmed/15687324) (https://www.ncbi.nlm.nih.gov/pubmed/15133511). - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 18, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24668887, 25351881, 31589614, 26337219, 20358599, 15687324, 15133511) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | This sequence change creates a premature translational stop signal (p.Arg162*) in the GALNT3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GALNT3 are known to be pathogenic (PMID: 15133511, 20358599). This variant is present in population databases (rs137853086, gnomAD 0.09%). This premature translational stop signal has been observed in individuals with tumoral calcinosis (PMID: 15133511, 24668887, 25351881, 26337219). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 7792). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at